We are live on ! Find out more
LCM

Lynwood Capital Management Portfolio holdings

AUM $16.9M
1-Year Est. Return 19.31%
This Fund
S&P 500
This Quarter Est. Return
+5.14%
1 Year Est. Return
-19.31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$93.2M
AUM Growth
-$11.3M
Cap. Flow
-$15.3M
Cap. Flow %
-16.41%
Top 10 Hldgs %
36.9%
Holding
211
New
99
Increased
20
Reduced
16
Closed
72
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSTR
51
DELISTED
Oyster Enterprises Acquisition Corp. Class A Common Stock
OSTR
$627K 0.67%
64,095
+11,719
+22% +$114K
COCH icon
52
Envoy Medical
COCH
$59.3M
$619K 0.66%
63,396
+8,590
+16% +$83.6K
DTRT
53
DELISTED
DTRT Health Acquisition Corp. Class A Common Stock
DTRT
$599K 0.64%
59,770
+9,770
+20% +$97.7K
JUN
54
DELISTED
Juniper II Corp.
JUN
$573K 0.62%
+57,546
New +$568K
BNC
55
CEA Industries
BNC
$100M
$565K 0.61%
+18,750
New +$491K
ZSQR
56
Z Squared Inc
ZSQR
$208M
$562K 0.6%
2,785
IBER
57
DELISTED
Ibere Pharmaceuticals
IBER
$504K 0.54%
51,400
-1
-0% -$10
FGMCU
58
DELISTED
FG Merger Corp. Unit
FGMCU
$503K 0.54%
+50,000
New +$501K
TGVC
59
DELISTED
TG Venture Acquisition Corp. Class A Common Stock
TGVC
$500K 0.54%
+50,492
New +$498K
STET
60
DELISTED
ST Energy Transition I Ltd.
STET
$494K 0.53%
+50,068
New +$492K
FNUC
61
Frontier Nuclear and Minerals Inc
FNUC
$48.7M
$470K 0.5%
+3,846
New +$325K
GAPA
62
DELISTED
G&P Acquisition Corp.
GAPA
$470K 0.5%
+47,347
New +$468K
CING icon
63
Cingulate
CING
$70.2M
$445K 0.48%
942
+421
+81% +$185K
HAIA
64
DELISTED
Healthcare AI Acquisition Corp. Class A Ordinary Shares
HAIA
$406K 0.44%
+41,006
New +$405K
MACC
65
DELISTED
Mission Advancement Corp.
MACC
$343K 0.37%
+35,000
New +$340K
BLU
66
DELISTED
BELLUS Health Inc.
BLU
$339K 0.36%
+49,300
New +$318K
IQMD
67
DELISTED
Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
$315K 0.34%
+31,454
New +$312K
MNTN
68
DELISTED
Everest Consolidator Acquisition Corporation
MNTN
$299K 0.32%
+30,150
New +$299K
BCSA
69
DELISTED
Blockchain Coinvestors Acquisition Corp. I Class A Ordinary Shares
BCSA
$298K 0.32%
+30,042
New +$297K
LGTOU
70
DELISTED
Legato Merger Corp. II Unit
LGTOU
$298K 0.32%
29,618
-170,382
-85% -$1.71M
CERO
71
DELISTED
CERo Therapeutics
CERO
$296K 0.32%
+15
New +$298K
TVGN icon
72
Tevogen Inc. Common Stock
TVGN
$27.3M
$259K 0.28%
+518
New +$258K
KRBP
73
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$256K 0.27%
10,000
-2,417
-19% -$71.5K
ACII
74
DELISTED
Atlas Crest Investment Corp. II
ACII
$251K 0.27%
+25,600
New +$250K
IVCB
75
DELISTED
Investcorp Europe Acquisition Corp I Class A Ordinary Shares
IVCB
$250K 0.27%
+25,000
New +$248K

Similar funds

Lynwood Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Lynwood Capital Management held 211 positions worth $93.2M, down 11% from $105M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Lynwood Capital Management withdrew a net $15.3M in Q1 2022, closing 72 positions and reducing 16 holdings. Its most notable exit was Golden Star Resources Ltd., an estimated $8.91M position sold in full.

By sector, the portfolio is most concentrated in Financials at 52% of assets, up from 23% a quarter earlier, followed by Materials and Healthcare.

Against the trend, Lynwood Capital Management opened a new position in iShares 20+ Year Treasury Bond ETF worth $3.3M.

  • Lynwood Capital Management's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 25,000 shares worth $3.3M.
  • Lynwood Capital Management added most to FirstMark Horizon Acquisition Corp. in Q1 2022, an estimated $698K increase.
  • Lynwood Capital Management's biggest Q1 2022 reduction was Omnichannel Acquisition Corp., cutting an estimated $2.09M.
  • Lynwood Capital Management fully exited Golden Star Resources Ltd. in Q1 2022, selling an estimated $8.91M.
  • Lynwood Capital Management's ten largest holdings make up 37% of its $93.2M portfolio in Q1 2022.
  • Lynwood Capital Management opened 99 new positions and closed 72 in Q1 2022.
  • Lynwood Capital Management's portfolio value fell 11% quarter-over-quarter to $93.2M.

Based on Lynwood Capital Management's 13F filing for Q1 2022, filed 5 May 2022.